These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18180082)

  • 1. Not just sheer luck! Immune correlates of protection against HIV-1 infection.
    Piacentini L; Fenizia C; Naddeo V; Clerici M
    Vaccine; 2008 Jun; 26(24):3002-7. PubMed ID: 18180082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging role of innate immunity in protection against HIV-1 infection.
    Lehner T; Wang Y; Pido-Lopez J; Whittall T; Bergmeier LA; Babaahmady K
    Vaccine; 2008 Jun; 26(24):2997-3001. PubMed ID: 18180080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immunity and HIV-1 infection.
    Lehner T; Wang Y; Whittall T; Seidl T
    Adv Dent Res; 2011 Apr; 23(1):19-22. PubMed ID: 21441475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells.
    Hladik F; Desbien A; Lang J; Wang L; Ding Y; Holte S; Wilson A; Xu Y; Moerbe M; Schmechel S; McElrath MJ
    J Immunol; 2003 Sep; 171(5):2671-83. PubMed ID: 12928421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host genetic factors that control immune responses to retrovirus infections.
    Miyazawa M; Tsuji-Kawahara S; Kanari Y
    Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women.
    Hirbod T; Broliden K
    J Intern Med; 2007 Jul; 262(1):44-58. PubMed ID: 17598814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing immunity to HIV through APOBEC.
    Harris RS
    Nat Biotechnol; 2008 Oct; 26(10):1089-90. PubMed ID: 18846074
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).
    Tomescu C; Abdulhaqq S; Montaner LJ
    Clin Exp Immunol; 2011 May; 164(2):158-69. PubMed ID: 21413945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orally exposed uninfected individuals have systemic anti-HIV responses associating with partners' viral load.
    Hasselrot K; Bratt G; Hirbod T; Säberg P; Ehnlund M; Lopalco L; Sandström E; Broliden K
    AIDS; 2010 Jan; 24(1):35-43. PubMed ID: 19779318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV pathogenesis: knowledge gained after two decades of research.
    Levy JA
    Adv Dent Res; 2006 Apr; 19(1):10-6. PubMed ID: 16672543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.
    Pinto LA; Sullivan J; Berzofsky JA; Clerici M; Kessler HA; Landay AL; Shearer GM
    J Clin Invest; 1995 Aug; 96(2):867-76. PubMed ID: 7635981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immunity in resistance to HIV infection.
    Biasin M; Clerici M; Piacentini L
    J Infect Dis; 2010 Nov; 202 Suppl 3():S361-5. PubMed ID: 20887225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.
    Price DA; O'callaghan CA; Whelan JA; Easterbrook PJ; Phillips RE
    Clin Sci (Lond); 1999 Dec; 97(6):707-18. PubMed ID: 10585898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men.
    Lo Caputo S; Trabattoni D; Vichi F; Piconi S; Lopalco L; Villa ML; Mazzotta F; Clerici M
    AIDS; 2003 Mar; 17(4):531-9. PubMed ID: 12598773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activation.
    Suy A; Castro P; Nomdedeu M; García F; López A; Fumero E; Gallart T; Lopalco L; Coll O; Gatell JM; Plana M
    J Infect Dis; 2007 Oct; 196(8):1191-201. PubMed ID: 17955438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-chemokines and protection from HIV type 1 disease.
    Garzino-Demo A; DeVico AL; Cocchi F; Gallo RC
    AIDS Res Hum Retroviruses; 1998 Jun; 14 Suppl 2():S177-84. PubMed ID: 9672236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune correlates of HIV exposure without infection in foreskins of men from Rakai, Uganda.
    Prodger JL; Hirbod T; Kigozi G; Nalugoda F; Reynolds SJ; Galiwango R; Shahabi K; Serwadda D; Wawer MJ; Gray RH; Kaul R;
    Mucosal Immunol; 2014 May; 7(3):634-44. PubMed ID: 24150258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous and antigen-induced chemokine production in exposed but uninfected partners of HIV type 1-infected individuals in North India.
    Suresh P; Wanchu A; Bhatnagar A; Sachdeva RK; Sharma M
    AIDS Res Hum Retroviruses; 2007 Feb; 23(2):261-8. PubMed ID: 17331032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
    Borghan MA; Oka S; Takiguchi M
    Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro.
    Kinter AL; Horak R; Sion M; Riggin L; McNally J; Lin Y; Jackson R; O'shea A; Roby G; Kovacs C; Connors M; Migueles SA; Fauci AS
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):438-50. PubMed ID: 17411377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.